Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
9.74
+0.05 (0.52%)
Nov 22, 2024, 4:00 PM EST - Market closed
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $1.57 billion as of November 22, 2024. Its market cap has decreased by -11.16% in one year.
Market Cap
1.57B
Enterprise Value
1.24B
1-Year Change
-11.16%
Ranking
Category
Stock Price
$9.74
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $1.57B, a decrease of -39.08%. That is a compound annual growth rate of -34.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 1.58B | -39.25% |
| Dec 29, 2023 | 2.60B | 0.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunocore Holdings | 1.62B |
| InMode | 1.61B |
| Viridian Therapeutics | 1.60B |
| Travere Therapeutics | 1.59B |
| BioCryst Pharmaceuticals | 1.57B |
| Evotec SE | 1.57B |
| Nurix Therapeutics | 1.56B |
| Kiniksa Pharmaceuticals International, | 1.54B |